· 1dPfizer's Strategic Appointment: Former FDA Director Takes the Helm as Chief Medical Officer
Pfizer appoints Patrizia Cavazzoni as chief medical officer, the U.S. delays the definition of 'healthy' on labels, issues with Wegovy and Ozempic's drug shortages lead to lawsuits, new outbreaks of listeria are under investigation,
The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...
But the direct-to-consumer ad didn't come from Palo Alto-based Bridge Bio (Nasdaq: BBIO); instead it was produced by Pfizer ...
The biotech contends its drug is a better stabilizer than the drugs marketed by Pfizer. For 2024, Pfizer reported $3.3 billion in revenue from its Vyndaqel family of TTR stabilizers, a 36% ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback